2nd try: soy and its effect post menopausally

[Guest guest]

Hope this one takes .... sorry about the first one: operator error, most likely. Sunny

Sunny Kierstyn, RN DC Fibromyalgia Care Center of Oregon 2677 Willakenzie Road, 7C

Eugene, Oregon, 97401

541- 344- 0509; Fx; 541- 344- 0955

From: "Dr.Feelgood" <emumbauer@...>Reply-"Dr.Feelgood" <emumbauer@...>chirolist-ca@...Subject: [Chirolist-CA] evaluate behavior of sternocleidomastoid muscle MVADate: Wed, 26 Jul 2006 02:49:16 -0400 (EDT)All communication within this forum is private and is for the benefit of the members of this forumand may NOT be forwarded without express permission from the list administrators.******************************************************************European Journal of NutritionPublisher: SteinkopffISSN: 1436-6207 (Paper) 1436-6215 (Online)DOI: 10.1007/s00394-006-0602-2Issue: Online FirstORIGINAL CONTRIBUTIONSoy isoflavones attenuate bone loss in early postmenopausal Chinese womenA single-blind randomized, placebo-controlled trialYan-Bin Ye1, 2, Xing-Yi Tang3, n A. Verbruggen4 and Yi-Xiang Su1(1) Dept. of Nutrition, School of public Health Sun Yat-sen University, 74 Zhongshan Rd 2, Guangzhou, 510080, P.R. China(2) Dept. of Nutrition, The First Affiliated Hospital Sun Yat-sen University, Guangzhou, P.R. China(3) Dept. of Paediatrics, The Third Affiliated Hospital Sun Yat-sen University, Guangzhou, P.R. China(4) Acatris Holding B.V., ZG Giessen, The NetherlandsReceived: 8 November 2005 Accepted: 28 April 2006 Published online: 8 June 2006AbstractBackground Previous studies show that daily doses of 40–99 mg soy isoflavones produce inconsistent effects on preventing estrogen-related bone loss in postmenopausal women.Aim of the study To examined the bone-sparing effect of isoflavones at a higher dose in early Chinese postmenopausal women.Methods A total of 90 eligible women aged 45–60 years were randomly assigned to three treatment groups (30 subjects/group) with daily dosages of 0 (placebo), 84 and 126 mg isoflavones for 6 months. Further inclusion criteria included body mass index <30 kg/m2 and Kuppermann Climacteric Scale >15. Bone mineral density (BMD) of the spine and hip were measured using dual- energy X-ray absorptiometry at 0 and 6 months. Serum osteocalcin, bone-specific alkaline phosphatase (BAP) and urinary deoxypyridinoline were examined at 0, 3 and 6 months.Results Mean percent changes in BMD at the lumbar spine (p = 0.114) and femoral neck (p = 0.053) increased with the supplementations of soy isoflavones after adjusting for age, years since menopause, body weight and height, dietary intakes of isoflavones, calcium and protein, physical activities and baseline BMD at the relevant sites. We observed significantly dose-dependent linear relationship between the supplemental isoflavones and percent changes of BMD at the spine (p = 0.042) and femoral neck (p = 0.016) post-treatment, and urinary total deoxypyridinoline (p = 0.014) at 12 weeks but not at 24 weeks after adjusting for the above factors. No significant difference in percent changes in serum osteocalcin (p > 0.05) and BAP (p > 0.05) was found among the three treatment groups at 12-week and 24-week post-treatment.Conclusion There is a significantly dose-dependent effect of soy isoflavones on attenuating bone loss at the spine and femoral neck possibly via the inhibition of bone resorption in non-obese postmenopausal Chinese women with high Kuppermann Scale.********************************************************************************"Building Chiropractic Community through enhanced communication."To change your preferences or unsubscribe:http://ww3.chirolists.com/mailman/listinfo/chirolist-caemail: Chirolist-CA-request@...?subject=unsubscribeList options tutorial:http://www.chirolists.com/index.cfm?nid=6Email filters tutorial:http://www.chirolists.com/index.cfm?nid=7********************************************************************************* Call friends with PC calling -- FREE